Sanofi-Aventis SA is close to announcing a deal to buy Merck & Co.'s half of a joint venture that makes drugs for animals, according to people familiar with the matter. Analysts and bankers value Merck's 50% stake in the Merial joint venture...
This item provided by The Wall Street Journal Europe
No comments:
Post a Comment